or Try an Advanced Search...

    Diagnostic Tests Stocks List

    Symbol Grade Name % Change
    BIAF F bioAffinity Technologies, Inc. -2.76
    MYGN F Myriad Genetics, Inc. 0.36
    TTOO F T2 Biosystems, Inc. -1.93
    MYNZ F Mainz Biomed B.V. -7.01
    TRIB F Trinity Biotech plc 0.00
    CODX F Co-Diagnostics, Inc. 1.92
    ATOS F Atossa Genetics Inc. -0.83
    OCX F OncoCyte Corporation -2.91
    INBS D Intelligent Bio Solutions Inc. 17.14
    ADPT C Adaptive Biotechnologies Corporation -1.13
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Medical Devices Medical Distribution
    Related Stock Lists: Medicine Medical Test Cancer Clinical Medicine Biomarkers Biotechnology Disease Infectious Diseases Molecular Diagnostics Pancreatic Cancer Acid Blood Test Cell Biology Colorectal Cancer Diabetes Diagnostic Products Glucose HIV Innogenetics Kidney Disease

    Related ETFs - A few ETFs which own one or more of the above listed Diagnostic Tests stocks.

    Symbol Grade Name Weight
    XHS D SPDR S&P Health Care Services ETF 4.88
    CAMX A The Advisors? Inner Circle Fund Cambiar Aggressive Value ETF 4.59
    PBE D PowerShares Dynamic Biotech & Genome 4.39
    EDOC C Global X Telemedicine & Digital Health ETF 4.28
    LSAT A LeaderShares AlphaFactor Tactical Focused ETF 3.5
    View all Diagnostic Tests ETFs...
    Compare ETFs
    Compare CAMX to LSAT Compare XHS to LSAT Compare XHS to PBE

        Diagnostic Tests Stocks Recent News

        Date Stock Title
        Nov 21 INBS Intelligent Bio Solutions to Participate in the Noble Capital Markets’ 20th Annual Emerging Growth Equity Conference
        Nov 21 ATOS Atossa Therapeutics to Present Poster on (Z)-Endoxifen at AACR Special Conference in Cancer Research
        Nov 20 MYGN Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina’s Updated Comprehensive Gene Panel Assay, TruSight™ Oncology 500 v2
        Nov 20 ATOS Atossa Therapeutics Announces Five Abstracts Highlighting (Z)-Endoxifen Research Accepted for Presentation at the 2024 San Antonio Breast Cancer Symposium
        Nov 19 MYGN Myriad Genetics Announces Prequel® Prenatal Screening Can Now be Performed Eight Weeks into Pregnancy
        Nov 19 MYGN Myriad Genetics price target lowered to $21 from $32 at Morgan Stanley
        Nov 18 INBS INBS Stock Declines Despite Positive Results of Pharmacokinetic Study
        Nov 18 ATOS Is Intuitive Surgical (ISRG) Outperforming Other Medical Stocks This Year?
        Nov 16 TRIB Trinity Biotech PLC (TRIB) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ...
        Nov 15 TRIB Trinity Biotech files to sell 0.65M American Depositary shares by selling shareholders
        Nov 15 TRIB Trinity Biotech Plc (TRIB) Q3 2024 Earnings Call Transcript
        Nov 15 ADPT Wall Street Analysts Predict a 31.36% Upside in Adaptive Biotechnologies (ADPT): Here's What You Should Know
        Nov 15 TRIB Trinity Biotech Announces Q3 2024 Financial Results
        Nov 15 TRIB Earnings Scheduled For November 15, 2024
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Medical Devices Medical Distribution
        Related Stock Lists: Medicine Medical Test Cancer Clinical Medicine Biomarkers Biotechnology Disease Infectious Diseases Molecular Diagnostics Pancreatic Cancer Acid Blood Test Cell Biology Colorectal Cancer Diabetes Diagnostic Products Glucose HIV Innogenetics Kidney Disease
        Diagnostic Tests

        Diagnostic tests are medical tests, procedures, or scans that doctors use to diagnose a medical condition. These tests help doctors determine the cause of a patient’s symptoms and decide on the best course of treatment. Diagnostic tests can include blood tests, imaging tests, such as X-rays and CT scans, and other procedures, such as endoscopies and biopsies.

        Browse All Tags